Nasdaq:US$38.93 (+1.39) | HKEX:HK$61.00 (+0.90) | AIM:£5.67 (+0.11)
主要股東

和黃醫藥共發行864,417,280 股普通股。 於納斯達克上市的每股美國存託股份(ADS)相當於五股普通股。

僅作說明:如果轉換所有普通股, 則相當於172,883,456股納斯達克交易的ADS。

就和黃醫藥而言,其已發行股本中約40.6%並非由公眾持有,而是由和黃醫藥的董事及長江和記實業有限公司持有。長江和記實業有限公司為和黃醫藥主要股東。

和黃醫藥股本中之主要和重大權益的披露受 (i) 英國金融行為監管局 (U.K. Financial Conduct Authority) 披露指引及透明度規則(Disclosure Rules and Transparency Rules)第 5 章條文規定(已被納入本公司的組織章程細則);以及(ii) 美國 1934 年證券交易法的約束。

就和黃醫藥所知,持有和黃醫藥已發行股本之3% 或以上的股東及其董事(截至上次更新)的權益載於下表。

最後更新時間:2021年 9月 13日

主要股東

股東所持普通股數目(包括美國存託股份)所佔已發行股本的概約百分比
CK Hutchison Holdings Limited (1)332,502,74038.47%
The Capital Group Companies, Inc. (2)77,676,0028.99%
JPMorgan Chase & Co. (3)51,312,7345.94%
CA Fern Parent (4)(5)40,847,5004.73%
Prudential plc group(6)33,325,2953.86%
Canada Pension Plan Investment Board (5)(7)26,883,2703.11%
Jean Eric Salata (8)25,993,4453.01%
General Atlantic Singapore HCM Pte. Ltd.(5)(9)25,835,0002.99%

Note:
(1) As announced on June 30, 2021, the Company was notified by CK Hutchison Holdings Limited that it indirectly owned 332,502,740 ordinary shares. Pursuant to the Hong Kong Securities and Future Ordinance, CK Hutchison Holdings Limited filed a disclosure form 2 with the Hong Kong Stock Exchange on July 19, 2021. In addition to 332,478,770 ordinary shares (held through Hutchison Healthcare Holdings Limited), the form 2 included 4,794 ADS (equal to 23,970 ordinary shares) currently held and 14,382 ADSs (equal to 71,910 ordinary shares) that will be transferred upon vesting of Long Term Incentive Plan awards.
(2) As of July 9, 2021, notified via disclosure form 2 filed with the Hong Kong Stock Exchange on July 16, 2021.
(3) As of July 8, 2021 notified via disclosure form 2 filed with the Hong Kong Stock Exchange on July 13, 2021.
(4) CA Fern Parent is wholly owned by several entities which are, by and through their control affiliates (including their respective general partners), ultimately controlled (directly or indirectly) by The Carlyle Group Inc., but The Carlyle Group Inc. has no beneficial interest in the underlying securities of the Company. As of Jun 30, 2021, notified via disclosure form TR-1 filed on AIM on July 2, 2021.
(5) Includes Shares subscribed for as a Cornerstone Investor in the Company’s Global Offering in June 2021.
(6) Held through indirect wholly-owned subsidiary M&G Investment Management Limited.  As notified on July 29, 2019, prior to the demerger of M&G plc from Prudential plc on October 21, 2019.
(7) As of June 30, 2021, notified via disclosure form TR-1 filed on AIM on July 16, 2020.
(8) Jean Eric Salata is Chief Executive and Founding Partner of Baring Private Equity Asia (“BPEA”). BPEA directly or indirectly controls several entities that hold voting rights in the Company. As of June 30, 2021, notified via disclosure form TR-1 filed on AIM on July 14, 2021.
(9) General Atlantic is entitled to further subscribe for up to 16,666,670 ordinary shares by exercising a warrant, in part or whole, at any time after July 2, 2020 and ending on January 3, 2022. As of July 6, 2020, notified via disclosure form TR-1 filed on AIM on July 6, 2020.

董事

董事所持普通股數目所持美國存託股份(ADS)數目所佔已發行股本的概約百分比
賀雋 (Christian Hogg)10,938,02068,0351.30%
鄭澤鋒2,561,46014,4010.30%
杜志強1,800,000133,2370.29%
施熙德700,000100,0000.14%
蘇慰國74,3170.04%
Dan Eldar19,00011,3900.009%
莫樹錦12,3990.007%
Paul Carter35,2402,0370.005%
Karen Ferrante8,1820.005%
Graeme Jack5,3970.003%

備註:「持有」是指直接或間接持有的董事賬戶和該董事的「緊密聯繫人」(根據歐盟市場濫用條例 (EU Market Abuse Regulation) 第3條(第596/2014號)的定義)持有的任何法律或實益權益)。